The remote patient monitoring (RPM) sector is entering a pivotal phase as new data from industry trackers, federal policy updates, and clinical deployments converge to redefine how chronic care is delivered outside traditional clinical settings. With the global RPM market projected to reach $2.4 billion by 2026—growing at a compound annual rate of 13.7%—providers, payers, and technology vendors are recalibrating strategies around scalability, interoperability, and long-term financial sustainability.

Market Momentum and Device Diversification

Recent quarterly earnings and funding rounds underscore the sector’s acceleration. In February 2025, digital health investment reached $3.1 billion, with RPM-specific platforms capturing 22% of that total—a notable increase from 14% in the same period last year. Leading the charge are multi-parameter devices that now integrate blood pressure, glucose, oxygen saturation, and weight metrics into a single wearable patch, reducing patient burden and improving adherence.

“We are seeing a decisive shift from single-vital-sign monitoring to holistic biometric tracking,” says Dr. Elena Vasquez, director of virtual care research at the Health Innovation Institute in Chicago. “The next generation of RPM is not just about collecting data—it’s about contextualizing that data with environmental, behavioral, and medication adherence inputs to predict deterioration before it occurs.”

One notable launch this quarter is theVitalBand Pro, a wrist-worn sensor that continuously streams electrocardiogram, respiratory rate, and activity data for up to 14 days. Its FDA-cleared algorithm uses a transformer-based neural network to flag early signs of congestive heart failure exacerbation, achieving a sensitivity of 94% in a 1,200-patient trial. The device is already being adopted by two major accountable care organizations in the Northeast.

CMS Reimbursement Expansion and New Coding Rules

Policy changes are equally transformative. In January 2025, the Centers for Medicare & Medicaid Services (CMS) finalized the 2025 Physician Fee Schedule, which introduces three new HCPCS codes (G0550, G0551, G0552) specifically for remote therapeutic monitoring (RTM) of musculoskeletal and behavioral health conditions. While RTM has existed since 2022, the new codes now allow reimbursement for patient-generated health data that includes medication ingestion tracking and digital exercise compliance—not just physiological vitals.

More critically, CMS has eliminated the “two-out-of-30-day” rule that previously required at least two readings per month for billing. Under the revised framework, providers can bill for continuous monitoring if the patient has at least one data transmission per week, with a minimum of 16 days of active monitoring per 30-day period. This change reduces administrative burden and aligns with asynchronous monitoring models used in postoperative recovery and oncology supportive care.

“The relaxation of frequency requirements is a double-edged sword,” cautions Mark Feldstein, a healthcare reimbursement attorney with Foley & Lardner LLP. “It encourages broader enrollment, but it also demands that providers demonstrate clinical value in their care management notes. Payers are increasingly auditing RPM programs for meaningful patient engagement, not just data collection.”

AI-Driven Predictive Analytics Moves from Pilot to Practice

The most significant trend in 2025 is the embedding of artificial intelligence into RPM platforms, moving beyond simple threshold alerts to predictive risk stratification. In a multi-site study published inNEJM Catalystlast month, a machine learning model trained on 1.8 million RPM patient-days reduced avoidable hospital readmissions for chronic obstructive pulmonary disease (COPD) by 38% compared to standard telemonitoring. The model factored in spirometry trends, weather pressure changes, and patient-reported dyspnea scores to generate personalized escalation protocols.

Vendor partnerships reflect this push. In March, ResMed announced a collaboration with Epic Systems to integrate its AirView RPM data directly into the electronic health record, using Epic’s Cosmos de-identified database to benchmark patient trajectories against regional cohorts. Similarly, Biofourmis and Oura Health have launched a joint offering that combines smart ring sleep data with cardiac medication titration algorithms for heart failure patients, with a planned randomized controlled trial enrolling 3,000 patients across 12 health systems.

However, experts warn that algorithmic transparency remains a barrier. “Clinicians need to understand why an AI model flags a patient as high risk, especially when it leads to home visits or medication changes,” says Dr. Priya Ramanathan, chief medical information officer at Stanford Health Care. “Explainable AI—where the model outputs the top contributing factors—is becoming a non-negotiable procurement criterion for hospital systems.”

Interoperability and Data Standardization Gains Traction

A persistent challenge—device interoperability—is seeing meaningful progress. The Office of the National Coordinator for Health Information Technology (ONC) released its updatedInteroperability Standards Advisoryin February, explicitly endorsing the HL7 FHIR R4 standard for RPM device communication, alongside the newPersonal Connected Health Alliance(PCHA) certification for Bluetooth Low Energy medical devices. This move aims to eliminate proprietary data silos that have historically forced hospitals to maintain multiple vendor dashboards.

In a practical demonstration, three major RPM vendors—Vivify Health, Current Health, and CareSimple—announced a joint pilot at the HIMSS 2025 conference in Las Vegas, allowing a single patient’s data from different devices to merge into one unified timeline within a common FHIR-based data lake. The pilot, involving 500 patients with hypertension and diabetes, will run through Q3 2025, with results expected to inform a national reference architecture for RPM data exchange.

The Home Hospital Effect and Workforce Implications

RPM’s expansion is closely tied to the growth of hospital-at-home (HaH) programs. According to the American Hospital Association, 322 hospitals across 40 states now operate CMS-approved acute care at home programs, up from 180 in 2023. RPM is the backbone of these programs, enabling continuous nurse oversight for patients receiving IV antibiotics or post-operative monitoring.

Yet workforce strain is emerging as a countervailing force. A survey by the American Telemedicine Association (ATA) found that 61% of RPM programs report difficulty hiring dedicated remote care nurses, with burnout rates 1.7 times higher than in ambulatory settings. To address this, some organizations are deploying “virtual nursing pools” that rotate across multiple RPM programs, supported by AI-generated daily summaries that prioritize high-acuity patients.

“RPM is no longer a pilot project; it is a core care delivery channel,” states Dr. Vasquez. “But without sustainable staffing models and payment parity for non-physician care managers, we risk widening the digital divide—where only affluent, tech-savvy patients reap the benefits.”

Looking Ahead: Value-Based Contracts and Consumer Wearables

The next 18 months will likely see RPM move further into value-based reimbursement. Major commercial payers, including UnitedHealthcare and Aetna, have begun offering premium reductions for Medicare Advantage enrollees who consistently transmit RPM data. Meanwhile, Apple and Google’s continued investment in health sensors on consumer devices—such as sleep apnea detection on the Apple Watch Series 10—is blurring the line between voluntary wellness tracking and prescribed clinical monitoring.

Regulatory bodies are responding. The FDA’s Digital Health Advisory Committee is currently deliberating on a new “Class II exemption” for low-risk RPM software that provides general wellness trends, potentially reducing premarket review time from nine months to four. If approved, this could accelerate the entry of consumer-grade RPM apps into the clinical mainstream.

As the sector matures, the central question is no longer whether RPM works—decades of evidence confirm it does—but how to scale it equitably, securely, and cost-effectively. With policy tailwinds, AI maturation, and growing payer acceptance, 2025 is shaping up as the year remote patient monitoring transitions from a supplementary tool to a foundational pillar of modern healthcare delivery.